目的对腋淋巴结阴性乳腺癌患者进行预后分析。
Objective To study the prognosis of axillary node negative breast cancer patients.
所有患者在确诊时均有淋巴结阴性乳腺癌以及处在绝经期。
All patients had lymph node-negative breast cancer and were postmenopausal at the time of diagnosis.
目的探讨定量病理技术对腋淋巴结阴性乳腺癌预后判断的应用价值。
Objective To study the prognostic identification of lymph node negative breast carcinoma by quantitative pathologic technique.
结论：MMP - 2蛋白在淋巴结阴性乳腺癌转移复发中起着重要作用，是重要的预后因子。
Conclusions: MMP-2 is an unfavorable prognostic factor in lymph node-negative breast carcinoma patients and it is an important prognostic factor.
原发性乳腺癌伴腋窝淋巴结阳性者端粒酶阳性表达率为95.83%（69/72），腋窝淋巴结阴性者端粒酶阳性表达率75%（42/56）。
Positive expression rate of telomerase in the patients with and without positive axillary lymph node were 95.83%(69/72) and 75(42/56), respectively.
乳腺癌组织中淋巴结转移阳性组CXCR3的表达率明显高于淋巴结转移阴性组（P＜0.05）；
The expression level of CXCR3 in the lymph node-positive group was higher than that in the lymph node-negative group ( P < 0. 05 ).
乳腺癌组织中淋巴结转移阳性组CXCR3的表达率明显高于淋巴结转移阴性组（P＜0.05）；
The expression level of CXCR3 in the lymph node-positive group was higher than that in the lymph node-negative group ( P < 0. 05 ).
应用推荐